Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#2026
ANI Pharmaceuticals, Inc. - Common Stock
81.2
6
USD
+0.18%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.18%
Monthly Change
+4.30%
6 month change
-3.49%
Year Change
-14.13%
Previous Close
81.1
1
Open
80.7
3
Low
80.0
9
High
81.3
0
Volume
18
Markets
US Stock Market
Healthcare
ANIP
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
22.75 M
Valuation ratios
Enterprise value
536.91 M
982.97 M
939.15 M
1.27 B
1.38 B
1.78 B
1.82 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
20.48
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
1.9
1.83
Price to cash flow ratio
22.76
174.72
20.86
8.75
16.68
9.05
8.04
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
0.82
Enterprise value to EBITDA ratio
18.76
131.78
11.02
7.45
10.08
6.08
5.08
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.02
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.05
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.79
10.85
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
60.59
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
16.38
EBITDA margin %
13.73
3.45
26.94
35.02
22.24
33.43
33.21
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
12.42
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
2.52
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
3.12
Inventory turnover
—
1.41
1.48
1.68
2.02
2.39
0.65
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.61
0.17
Solvency ratios
Debt to assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.21
Debt to equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
0.54
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9.96
EBIT per share
-1.34
-3.16
-2.17
2.58
0.03
5.23
5.85
EBITDA per share
2.39
0.59
5.24
9.37
7.07
13.91
16.93
Total debt per share
15.52
22.81
17.62
15.7
16.49
13.75
14.17
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
14.44
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
34.68
Tangible book value per share
16.36
26.51
19.29
23.79
20.9
-0.06
1.52
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
23.56
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
26.1
News
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
ANIP Valuation: Does 9.8x Forward P/E Offer Upside?
ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge
ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised
Zacks.com featured highlights include ANI, Cummins and Seadrill
3 Stocks Showing Powerful Earnings Acceleration This May
ANI Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ANIP) 2026-05-08
ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say
ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates
Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue Estimates